Clinical Trial Update: A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)

View source ↗

Summary

This document describes a multicenter real-world study protocol to evaluate the effectiveness and safety of vorasidenib in patients with IDH-mutant grade 2 astr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Idh-mutant
• Oligodendroglioma Idh-mutant

Drugs mentioned

• Vorasidenib (vorasidenib)

Snippet

Sponsor: Servier (Tianjin) Pharmaceutical Co. LTD. | Conditions: Gliomas | Status: NOT_YET_RECRUITING